Table 2.
Patients group A (N = 23) with PCa, way of treatment. CNB and prostate data. Number of patients with epithelial cellular material in peripheral blood before and after CNB and increased score. Individuals in each group C, D, E are also presented in Table 3.
| Group A = C + D + E vol = volume P = prostate |
C PCa prostatectomy (N = 10) |
D PCa radiation (N = 2) |
E PCa active surveillance (N = 11) |
|---|---|---|---|
| CNB vol mm3 | 85.1 (71.9–107.2) | 100.6 (95.1–106) | 97 (72–117.2) |
| CNB vol/P vol | 1/510 | 1/480 | 1/620 |
| CNB PCa vol mm3 mean and range share of P vol | 13.2 (1.3–34) mean 1/2800 |
46.4 (4.3–89) mean 1/1000 |
2.7 (0.3–13.9) mean 1/21000 |
| CNB Ca vol/CNB vol, % | 19 (1.1–25.3) | 40 (5–84) | 3 (0.3–14) |
| Gleason score | 7 (6–8) | 8.5 (7–10) | 6 (5–7) |
| P vol cm3
Way of calculation |
32.2 (24–46.9) Postop. |
41.5 (40–43) TRUS |
47.9 (16–75) TRUS |
| PCa vol from postoperative serial sections, cm3 | 4.3 (1.2–8.4) (3.6–23.5%, mean 13.4% of P vol.) |
Not available | Not available |
| Epithelial cellular material | |||
| Before CBN | 4 patients | 0 patients | 5 patients |
| After CNB | 9 patients | 2 patients | 8 patients |
| Increased score | 6 patients | 2 patients | 6 patients |